Victory Capital Management Inc. Raises Position in MiMedx Group, Inc. (NASDAQ:MDXG)

Victory Capital Management Inc. grew its position in MiMedx Group, Inc. (NASDAQ:MDXG) by 2.8% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 142,350 shares of the company’s stock after purchasing an additional 3,901 shares during the quarter. Victory Capital Management Inc.’s holdings in MiMedx Group were worth $841,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Blue Trust Inc. bought a new stake in shares of MiMedx Group in the third quarter worth approximately $30,000. Point72 Asset Management L.P. bought a new stake in shares of MiMedx Group in the second quarter worth approximately $40,000. Entropy Technologies LP bought a new stake in shares of MiMedx Group in the third quarter worth approximately $64,000. Quest Partners LLC bought a new stake in shares of MiMedx Group in the second quarter worth approximately $81,000. Finally, Aigen Investment Management LP bought a new stake in shares of MiMedx Group in the third quarter worth approximately $83,000. 79.15% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently commented on MDXG shares. Cantor Fitzgerald reiterated an “overweight” rating and issued a $11.00 price target on shares of MiMedx Group in a research note on Thursday, August 1st. StockNews.com lowered shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a research report on Friday, November 8th. Finally, Craig Hallum cut their target price on shares of MiMedx Group from $14.00 to $12.00 and set a “buy” rating for the company in a research report on Thursday, August 1st. Six research analysts have rated the stock with a buy rating, According to MarketBeat.com, MiMedx Group currently has an average rating of “Buy” and a consensus price target of $12.00.

MiMedx Group Stock Performance

MDXG opened at $9.43 on Thursday. The firm has a market cap of $1.39 billion, a P/E ratio of 17.15 and a beta of 1.94. MiMedx Group, Inc. has a 1-year low of $5.47 and a 1-year high of $9.64. The company has a 50 day simple moving average of $6.79 and a two-hundred day simple moving average of $6.88. The company has a debt-to-equity ratio of 0.10, a current ratio of 4.10 and a quick ratio of 3.53.

MiMedx Group Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.